Knowledge Hub

HistoGeneX NV - Product Pipeline Analysis, 2016 : Business Description, Key Company Facts, Products and Services, Key Competitors, Key Employees

Press Release   •   Feb 08, 2017 05:42 EST

HistoGeneX NV (HistoGeneX) is a biotechnology company that offers clinical research services. The company offers research, clinical research and patient testing services. It handles human biological specimens and deploys technologies to interrogate the DNA, RNA and proteins to categorize, enumerate and understand cancer for research and diagnostic applications. HistoGeneX provides biomarker assay development and validation services, TMA services, skin nerve fiber assay, pathology and biomarker assessment services. It offers morphology based tests that include IHC, IF, real-time PCR, epigenetics, multi-analyte IHC/IF and spectral imaging. The company offers tissue morphology-based lab research services to pharmaceutical, medical device, and academic clients. HistoGeneX is headquartered in Antwerpen, Belgium.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

View Report @ http://www.marketresearchreports.biz/analysis/954999

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company HistoGeneX NV
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Get Sample Copy Of This Report @
http://www.marketresearchreports.biz/sample/sample/954999

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
HistoGeneX NV Company Overview 5
HistoGeneX NV Company Snapshot 5
HistoGeneX NV Pipeline Products and Clinical Trials Overview 5
HistoGeneX NV Pipeline Analysis Overview 8
Key Facts 8
HistoGeneX NV - Major Products and Services 9
HistoGeneX NV Pipeline Products by Development Stage 10
HistoGeneX NV Pipeline Products Overview 12
IHC Based Diagnostic Assay - Bcl-2:IGH 12
IHC Based Diagnostic Assay - Bcl-2:IGH Product Overview 12
IHC Based Diagnostic Assay - BRCA 13
IHC Based Diagnostic Assay - BRCA Product Overview 13
IHC Based Diagnostic Assay - EBER 14
IHC Based Diagnostic Assay - EBER Product Overview 14
IHC Based Diagnostic Assay - GATA-3 15
IHC Based Diagnostic Assay - GATA-3 Product Overview 15
IHC Based Diagnostic Assay - HLA - DR 16
IHC Based Diagnostic Assay - HLA - DR Product Overview 16
IHC Based Diagnostic Assay - HPV 17
IHC Based Diagnostic Assay - HPV Product Overview 17
IHC Based Diagnostic Assay - ICOS 18
IHC Based Diagnostic Assay - ICOS Product Overview 18
IHC Based Diagnostic Assay - IDO 19
IHC Based Diagnostic Assay - IDO Product Overview 19
IHC Based Diagnostic Assay - Phospho-PRAS40 20
IHC Based Diagnostic Assay - Phospho-PRAS40 Product Overview 20
IHC Based Diagnostic Assay - Phospho-STAT3 21
IHC Based Diagnostic Assay - Phospho-STAT3 Product Overview 21
IHC Based Diagnostic Assay - Vimentin 22
IHC Based Diagnostic Assay - Vimentin Product Overview 22
IHC Based Diagnostic Assay - VISTA 23
IHC Based Diagnostic Assay - VISTA Product Overview 23
IHC Based Diagnostic Assay -E-cadherin 24
IHC Based Diagnostic Assay -E-cadherin Product Overview 24
HistoGeneX NV - Key Competitors 25
HistoGeneX NV - Key Employees 26
HistoGeneX NV - Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
HistoGeneX NV, Recent Developments 28
Jun 02, 2014: MDxHealth and HistoGeneX Awarded $1.8 Million IWT Grant to Develop Companion Diagnostics for Cancer Immunotherapy 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.